NEWS IMPULSE DYNAMICS ANNOUNCES FIRST OPTIMIZER IMPLANT IN CHINA Breakthrough CCM Therapy Now Being Implemented in China MARLTON, N.J., November 1, 2021 — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart...

PRESS RELEASE FDA Authorizes Removal of “NSR” From Indications for Use MARLTON, N.J., October 26, 2021 — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), today announced that the U.S. Food and...

NEWS Impulse Dynamics Announces First Heart Failure Patient Treated with CCM Therapy in Brazil Breakthrough Therapy Now Commercially Available in South America’s Most Populous Country MARLTON, N.J. – January 05, 2021 – Impulse Dynamics, a company dedicated to...

NEWS Impulse Dynamics Announces Publication of Data from FIX-HF-5C2 Study Evaluating the Two-Lead Optimizer System Availability of the two-lead device represents a significant advancement in the development of cardiac contractility modulation therapy for patients...

NEWS Impulse Dynamics Announces First Enrollment in Post-Approval Study of CCM Therapy Delivered by the Optimizer System Post-Approval Study will evaluate real-world safety and efficacy evidence for breakthrough heart failure therapy MOUNT LAUREL, N.J. – March 17,...

NEWS Impulse Dynamics Appoints Medical Director to Leadership Team Ishu Rao, M.D., brings wealth of clinical expertise during time of rapid company growth MOUNT LAUREL, N.J. – March 10, 2020 Impulse Dynamics, a company dedicated to improving the lives of people...

NEWSIMPULSE DYNAMICS SECURES $80.25 MILLION FINANCINGFunding to Accelerate Commercialization of the Optimizer Smart System for Heart Failure MOUNT LAUREL, N.J. – December 3, 2019 – Impulse Dynamics, developer of Optimizer® Smart System for delivering CCM™ therapy,...

NEWSImpulse Dynamics Secures Transitional Pass-through (TPT) Incremental Payment for the Optimizer Smart System2020 Payment Rules from the Centers for Medicare and Medicaid Services Bring CCM Therapy to Heart Failure Patients in the Outpatient Setting Mount Laurel,...

NEWSFirst Optimizer® Smart Device Implanted in ChinaMount Laurel, NJ, November 1, 2019 – On October 29, 2019, the first Optimizer Smart Cardiac Contractility Modulation CCMTM device was implanted in China at the Boao Super Hospital. Impulse Dynamics’ Optimizer...

NEWSImpulse Dynamics Announces U.S. FDA Supplemental-PMA Approval of its Next Generation Optimizer® Smart SystemCommercial-Ready Device to Deliver Improved Outcomes to Heart Failure Patients MOUNT LAUREL, N.J. – October 30, 2019 – Impulse Dynamics, developer of the...

NEWSImpulse Dynamics receives FDA approval for breakthrough Optimizer® Smart System delivering CCM™ therapy for treatment of heart failureOrangeburg, New York, March 21, 2019 – Impulse Dynamics, developer of the implantable Optimizer® Smart System for delivering...

NEWSClinical Registry Data and recently published FIX-HF-5C were presented at the Late-Breaking Clinical Trial Session at EHF 2018Stuttgart, Germany, May 28th, 2018 – Impulse Dynamics Germany, GmbH announced results on “Real World” experience from its European...

NEWSFIX-HF-5C Late-Breaking Clinical Trial Data Presented at HRS 2018 with Simultaneous Publication in the JACC: Heart FailureOrangeburg, New York, May 10, 2018 – Impulse Dynamics (USA), Inc. announced results from its FIX-HF-5C randomized, Controlled Trial of...

NEWSThe CFDA Approves Impulse Dynamics’ Optimizer System for Treatment of Chronic Heart Failure in ChinaOrangeburg, New York & Stuttgart, Germany. December 18, 2017 – The China Food and Drug Administration (CFDA) has approved Impulse Dynamics’ Optimizer® system...

NEWSImpulse Dynamics Announces First US Implant in the FIX-HF-5CA Continued Access Study.Orangeburg, New York. August 7, 2017 – Impulse Dynamics announced today the first implant in the Company’s FIX-HF-5CA Continued Access Study. The FIX-HF-5CA study is a...

NEWSImpulse Dynamics Completes $45 million Financing RoundStuttgart, May 11, 2017 – Impulse Dynamics, developer of the revolutionary Cardiac Contractility Modulation (CCM) technology for treatment of Chronic Heart Failure (CHF), announced today that the company has...

NEWSImpulse Dynamics Successfully Launches the Optimizer Smart Device for Heart Failure Treatment in EuropeImpulse Dynamics has launched the next generation of its Optimizer device, the Optimizer Smart, in Europe after it received the CE mark. The Optimizer Smart...

NEWSImpulse Dynamics Recognized with Frost & Sullivan’s 2016 New Product Innovation AwardSeptember 12, 2016 – Impulse Dynamics, developer of the Optimizer™ IVs implantable device for the treatment of Chronic Heart Failure (CHF), is the recipient of the...

NEWSImpulse Dynamics Completes $30 Million Financing RoundMt. Laurel, New Jersey, May 13 2016 – Impulse Dynamics, developer of the Optimizer™ IVs implantable device for treatment of chronic heart failure (CHF), announced today that the company has closed a $30...

NEWSContinued growth within Europe – Impulse Dynamics announces the first implantations of the Optimizer IVs device in the Slovenia.Stuttgart, Germany, March 2016 - Impulse Dynamics announced the first two implantations of its Optimizer IVs device in Slovenia. The...

NEWSImpulse Dynamics Opens its Hong Kong Sales and Support OfficeHong Kong, China – January 11th, 2016 – Impulse Dynamics NV (Impulse), the developer of the Optimizer™ IVs implantable device, is pleased to announce the official opening of its Hong Kong sales and...

NEWSContinued Expansion for Impulse Dynamics’ Optimizer™ IVs Device – First Implant in the Emirate of Sharjah (UAE)Stuttgart, Germany, November 11th, 2015 – Impulse Dynamics reported today the first implantation of its Optimizer IVs device in the Emirate of Sharjah...

NEWS First Implant in the Kingdom of Saudi Arabia – Continued Global Growth for Impulse Dynamics’ Optimizer IVs Device. Stuttgart, Germany – August 23rd, 2015 – Impulse Dynamics announced today (23 August, 2015) the first implantation of its Optimizer IVs device in...

NEWSImpulse Dynamics announced the first implantation of the Optimizer IVs device in PolandStuttgart, Germany – August 13th, 2015 – Impulse Dynamics announced today (13 August, 2015) the first implantation of its Optimizer IVs device in Poland, at the University...

NEWSContinued Expansion for Impulse Dynamics Optimizer IVs device – First implantations in SwitzerlandStuttgart, Germany – August 6th, 2015 – Impulse Dynamics, announced today the first implantation of its Optimizer IVs device in Switzerland, continuing the global...

NEWSImpulse Dynamics announces the first implantation of the Optimizer IVs device in a patient with a concomitant S-ICD in the United StatesOrangeburg, New York – July 28, 2015 – Impulse Dynamics (USA), Inc. announced that Cardiac electrophysiologist, Andrew...

NEWSImpulse Dynamics announced the first implantation of the Optimizer IVs device in ChinaStuttgart, Germany – 9 January, 2015 – Impulse Dynamics announced today the first implantation of its Optimizer IVs device in China.  The Optimizer IVs is a minimally invasive...

NEWSImpulse Dynamics announced the first implantation of the Optimizer IVs device in RussiaStuttgart, Germany – December, 2014 – Impulse Dynamics announced the first implantation of its Optimizer IVs device in Russia.  The Optimizer IVs is a minimally invasive...